(Q36037758)

11 August 2017

1 reference

title

Formation of bradykinin: a major contributor to the innate inflammatory response (English)

1 reference

11 August 2017

0 references

Kusumam Joseph

1

1 reference

11 August 2017

Allen P Kaplan

series ordinal

2

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

published in

Advances in Immunology

1 reference

11 August 2017

volume

86

1 reference

11 August 2017

page(s)

159-208

1 reference

Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of the coagulation pathway during ongoing allergic cutaneous reactions in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Factor XI, but not prekallikrein, blocks high molecular weight kininogen binding to human umbilical vein endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Influx of kininogens into nasal secretions after antigen challenge of allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Role of blood coagulation factor XI in downregulation of fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Factor XII and prekallikrein-kallikrein-kinin in the cryoactivation of human plasma prorenin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Rapid induction of Alzheimer A beta amyloid formation by zinc.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Angiotensin-Converting Enzyme: Vascular Endothelial Localization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Dissemination of contact activation in plasma by plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of plasminogen by human plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Brief recordings. Rheumatoid arthritis in a patient with Hageman trait

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Formation and structure of human Hageman factor fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

An enzyme in human blood plasma that inactivates bradykinin and kallidins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Factor XI activation in a revised model of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of the classical pathway of complement by Hageman factor fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Mechanisms of activation of the classical pathway of complement by Hageman factor fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography, characterization and isolation of an active fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Receptors for high molecular weight kininogen on stimulated washed human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

High molecular weight kininogen binds to unstimulated platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Human high molecular weight kininogen as a thiol proteinase inhibitor: presence of the entire inhibition capacity in the native form of heavy chain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Kinin system responses in sepsis after trauma in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Separation of Two Different Substrates for Plasma Kinin-forming Enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Bradykinin receptor modulation in cellular models of aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Kinetic analysis of plasminogen activation by purified plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of the kinin-forming cascade on the surface of endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of the bradykinin-forming cascade on endothelial cells: a role for heat shock protein 90

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Pathways for bradykinin formation and inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Completion of the primary structure of human high-molecular-mass kininogen. The amino acid sequence of the entire heavy chain and evidence for its evolution by gene triplication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Cold-promoted activation of factor VII in human plasma: studies on the associated acyl-argin?ne esterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Factor XII deficiency in a man with gout and angioimmunoblastic lymphadenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Human low-molecular-mass kininogen. Amino-acid sequence of the light chain; homology with other protein sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

1 reference

7 January 2021

Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Inhibitors of kallikrein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies on Human High Molecular Weight (HMW) Kininogen. II. Structural Change of HMW Kininogen by the Action of Human Plasma Kallikrein1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Limited proteolysis of human low-molecular-mass kininogen by tissue kallikrein. Isolation and characterization of the heavy and the light chains

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Inhibition of contact activation by a kininogen peptide (HKH20) derived from domain 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Plasma bradykinin in angio-oedema.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Local bradykinin generation in hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The Assay of a Plasma Component Necessary for the Generation of a Plasminogen Activator in the Presence of Hageman Factor (Hageman Factor Co-factor)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The conversion of C'IS to C'1 esterase by plasmin and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Coordinated ATP hydrolysis by the Hsp90 dimer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Endotoxin, prekallikrein, complement and systemic vascular resistance. Sequential measurements in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of the plasma kallikrein/kinin system on endothelial cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of the plasma kallikrein/kinin system on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The participation of plasma thromboplastin antecedent (Factor XI) in contact-activated fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Defective Activation of Clotting, Fibrinolytic, and Permeability-Enhancing Systems in Human Fletcher Trait Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Progress Curve Analysis of the Kinetics with Which Blood Coagulation Factor XIa Is Inhibited by Protease Nexin-2†

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Purified human plasma kallikrein aggregates human blood neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Mapping binding domains of kininogens on endothelial cell cytokeratin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Tranexamic Acid Therapy in Hereditary Angioneurotic Edema

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The mechanism of degradation of bradykinin (lysyl-bradykinin) in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Bradykinin antagonists: present progress and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Angioedema induced by a peptide derived from complement component C2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Mechanisms of angiotensin II-induced expression of B2 kinin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Kinetics of activation and autoactivation of human factor XII.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Kinetics of activation of prekallikrein by prekallikrein activator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Association of factor XI and high molecular weight kininogen in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Human plasma proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Inactivation of kallikrein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Interaction of human plasma kallikrein and its light chain with C1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Competitive antagonists of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Inactivation and binding of human plasma kallikrein by antithrombin III and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Prekallikrein deficiency in man

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Flaujeac trait. Deficiency of human plasma kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Second Kininase in Human Blood Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

The Mechanism by Which Heparin Promotes the Inhibition of Coagulation Factor XIa by Protease Nexin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Competitive analog antagonists of bradykinin in the canine hindlimb.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Amino acid sequence of the light chain of human high molecular mass kininogen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

Studies of the cleavage of human high molecular weight kininogen by purified plasma and tissue kallikreins, and upon contact activation of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2804%2986005-X

7 January 2021

10.1016/S0065-2776(04)86005-X

Identifiers

DOI

1 reference

11 August 2017

1 reference